AIRLINK 74.00 Decreased By ▼ -0.56 (-0.75%)
BOP 5.02 Decreased By ▼ -0.04 (-0.79%)
CNERGY 4.42 Decreased By ▼ -0.04 (-0.9%)
DFML 39.20 Decreased By ▼ -0.53 (-1.33%)
DGKC 86.09 Decreased By ▼ -1.46 (-1.67%)
FCCL 21.65 Decreased By ▼ -0.28 (-1.28%)
FFBL 34.01 Decreased By ▼ -0.58 (-1.68%)
FFL 9.92 Increased By ▲ 0.17 (1.74%)
GGL 10.56 Increased By ▲ 0.07 (0.67%)
HBL 113.89 Increased By ▲ 0.10 (0.09%)
HUBC 135.84 Decreased By ▼ -0.68 (-0.5%)
HUMNL 11.90 Increased By ▲ 1.00 (9.17%)
KEL 4.84 Increased By ▲ 0.17 (3.64%)
KOSM 4.53 Decreased By ▼ -0.11 (-2.37%)
MLCF 38.27 Decreased By ▼ -0.19 (-0.49%)
OGDC 134.85 Decreased By ▼ -1.29 (-0.95%)
PAEL 26.35 Decreased By ▼ -0.26 (-0.98%)
PIAA 20.80 Decreased By ▼ -1.69 (-7.51%)
PIBTL 6.68 Increased By ▲ 0.01 (0.15%)
PPL 123.00 Increased By ▲ 0.71 (0.58%)
PRL 26.69 Decreased By ▼ -0.28 (-1.04%)
PTC 14.33 Increased By ▲ 0.42 (3.02%)
SEARL 59.12 Decreased By ▼ -0.75 (-1.25%)
SNGP 69.50 Decreased By ▼ -0.56 (-0.8%)
SSGC 10.33 Decreased By ▼ -0.02 (-0.19%)
TELE 8.50 Decreased By ▼ -0.04 (-0.47%)
TPLP 11.23 Decreased By ▼ -0.11 (-0.97%)
TRG 64.85 Decreased By ▼ -1.15 (-1.74%)
UNITY 26.25 Decreased By ▼ -0.08 (-0.3%)
WTL 1.34 Decreased By ▼ -0.01 (-0.74%)
BR100 7,851 Increased By 26.3 (0.34%)
BR30 25,337 Decreased By -69.2 (-0.27%)
KSE100 75,207 Increased By 122.8 (0.16%)
KSE30 24,143 Increased By 49.1 (0.2%)

Coca-Cola Co on Tuesday raised its annual sales and profit forecasts for a second time this year, riding on resilient demand from consumers for its sodas, juices and energy drinks as well as higher prices.

Shares climbed 3% in early trading after the company also topped expectations for third-quarter results.

Rival PepsiCo also beat expectations and said it would hike prices next year as consumers continued to spend on products dubbed “affordable luxuries” at a time of elevated food prices and higher cost of living.

Coca-Cola’s average selling prices rose 9% in the third quarter, the company said, while overall unit case volumes increased 2%.

In an earnings call, CEO James Quincey said the company was monitoring the impact of weight-loss drugs and “there is still a lot of views out there as to what impact, if any, it will have.”

Investors have tracked comments from packaged food makers this earnings season on the potential impact from the surging popularity of weight-loss drugs such as Wegovy and Ozempic.

“It certainly feels that it has been a bit of an overreaction…as a pure liquids company and as more of a global company (Coca-Cola) will probably see the impact later than anyone,” said Markus Hansen, a portfolio manager at Vontobel Quality Growth. Coca-Cola accounts for 3.98% of Vontobel’s Global Equity strategy as of June 30.

The maker of Sprite and Fanta now sees full-year organic revenue growth of 10% to 11%, compared with its prior forecast of an increase of 8% to 9%.

Coca-Cola forecast annual core earnings per share to rise between 7% and 8%, compared to a 5% to 6% increase earlier.

Third-quarter net revenue of $11.91 billion topped estimates of $11.44 billion, while adjusted earnings of 74 cents per share also beat expectations of 69 cents, according to LSEG data.

Comments

Comments are closed.